Prosecution Insights
Prosecution Insights
5 pending office actions • 4 art units • 4 examiners • 0 of 5 (0%) have an AI response strategy ready • 6 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 5 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 5 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (40%) |
| §102 only | 1 (20%) |
| No statute on record | 2 (40%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BELYAVSKYI, MICHAIL A | 2 | 63.8% | +27.5% |
| XIAO, YAN | 1 | 67.9% | +51.5% |
| BARRERA, IMMACULADA | 1 | 28.6% | +83.3% |
| ZIEGLER, MATTHEW D | 1 | 47.5% | +53.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18042448 | SINGLE-DOMAIN ANTIBODIES THAT BIND SARS-COV-2 | BARRERA, IMMACULADA | 10d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17705082 | RESUSCITATION DOSING KIT | ZIEGLER, MATTHEW D | 154d overdue |
| 18042448 | SINGLE-DOMAIN ANTIBODIES THAT BIND SARS-COV-2 | BARRERA, IMMACULADA | 10d overdue |
| 18043497 | COMPOSITIONS AND METHODS FOR TARGETING PLASMODIUM MALE GAMETE PROTEIN TO BLOCK MALARIA PARASITE TRANSMISSION | XIAO, YAN | 7d |
| 18059369 | MODIFIED HEMATOPOIETIC STEM/PROGENITOR AND NON-T EFFECTOR CELLS, AND USES THEREOF | BELYAVSKYI, MICHAIL A | 7d |
| 17998206 | CHIMERIC ANTIGEN RECEPTORS (CARS) TARGETING NATURAL KILLER CELLS | BELYAVSKYI, MICHAIL A | 34d |
| Art Unit | Apps |
|---|---|
| 1644 | 2 |
| 1642 | 1 |
| 1671 | 1 |
| 3785 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18043497 | COMPOSITIONS AND METHODS FOR TARGETING PLASMODIUM MALE GAMETE PROTEIN TO BLOCK MALARIA PARASITE TRANSMISSION | XIAO, YAN | 1642 | §102 | Non-Final OA | 7d | Pending | Feb 28, 2023 |
| 18042448 | SINGLE-DOMAIN ANTIBODIES THAT BIND SARS-COV-2 | BARRERA, IMMACULADA | 1671 | Other | Non-Final OA | 10d overdue | Pending | Feb 21, 2023 |
| 18059369 | MODIFIED HEMATOPOIETIC STEM/PROGENITOR AND NON-T EFFECTOR CELLS, AND USES THEREOF | BELYAVSKYI, MICHAIL A | 1644 | Other | Final Rejection | 7d | Pending | Nov 28, 2022 |
| 17998206 | CHIMERIC ANTIGEN RECEPTORS (CARS) TARGETING NATURAL KILLER CELLS | BELYAVSKYI, MICHAIL A | 1644 | §103 | Non-Final OA | 34d | Pending | Nov 08, 2022 |
| 17705082 | RESUSCITATION DOSING KIT | ZIEGLER, MATTHEW D | 3785 | §103 | Final Rejection | 154d overdue | Pending | Mar 25, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial